Gsk annual capital expenditures (capex)
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Gsk Capital Expenditures (CapEx) Growth & History (GSK)
Gsk's capital expenditures (capex) was £1.35B for fiscal 2025.
View full Gsk company overviewGsk annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | £1.35B | −£51.0M | −3.65% |
| 2024 | 2024-12-31 | £1.40B | £85.0M | +6.47% |
| 2023 | 2023-12-31 | £1.31B | £171.0M | +14.96% |
| 2022 | 2022-12-31 | £1.14B | £193.0M | +20.32% |
| 2021 | 2021-12-31 | £950.0M | −£39.0M | −3.94% |
| 2020 | 2020-12-31 | £989.0M | −£276.0M | −21.82% |
| 2019 | 2019-12-31 | £1.26B | −£79.0M | −5.88% |
| 2018 | 2018-12-31 | £1.34B | −£201.0M | −13.01% |
| 2017 | 2017-12-31 | £1.54B | £2.0M | +0.13% |
| 2016 | 2016-12-31 | £1.54B | £163.0M | +11.81% |
| 2015 | 2015-12-31 | £1.38B | — | — |
Gsk quarterly capital expenditures (capex)
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | £653.0M | £20.0M | +3.16% |
| Q1 2026 | 2026-03-31 | £443.0M | — | — |
| Q4 2025 | 2025-12-31 | £1.02B | — | — |
| Q3 2025 | 2025-09-30 | £879.0M | — | — |
| Q2 2025 | 2025-06-30 | £633.0M | — | — |
Gsk capital expenditures (capex) trends
Over the last five fiscal years, Gsk's capital expenditures (capex) increased from £989.0M to £1.35B, a change of £359.0M. The latest reported quarter, Q2 2026, shows £653.0M.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Gsk source filings ↗